Neurotech Pharmaceuticals - Ownership and Business Overview

MediaCompany

Neurotech Pharmaceuticals Ownership

Who owns Neurotech Pharmaceuticals?

Neurotech Pharmaceuticals is owned by Triginta Capital. It was acquired on September 3, 2008.

Is Neurotech Pharmaceuticals PE-backed?

Yes. Neurotech Pharmaceuticals is owned by private equity investor Triginta Capital.

Neurotech Pharmaceuticals Business Overview

Where is Neurotech Pharmaceuticals headquartered?

Neurotech Pharmaceuticals is headquartered in Lincoln, Rhode Island.

What sector is Neurotech Pharmaceuticals in?

Neurotech Pharmaceuticals is a media company.

When was Neurotech Pharmaceuticals founded?

Neurotech Pharmaceuticals was founded in 1995.

Media M&A Summary in 2008

Out of 60 sectors in the Mergr database, media ranked 17 in number of deals in 2008. The largest media acquisition in 2008 was The Weather Company - which was acquired by Bain Capital Private Equity for $3.6B.

Join Mergr to view all 98 acquisitions of media companies in 2008, including 34 acquisitions by private equity firms, and 64 by strategics.

Neurotech Pharmaceuticals, Inc.

701 George Washington Highway,
Lincoln, Rhode Island 02865
United States,
(401)333-3880
www.neurotechusa.com

Developer of protein-drug delivery systems for the treatment of ophthalmologic diseases such as retinal degeneration (age-related macular degeneration, retinitis pigmentosa) and vascular eye diseases (diabetic retinopathy).


 Subscribe to unlock this and 208,151
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.